KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Receivables: 2010-2025

Historic Receivables for Opko Health (OPK) over the last 15 years, with Sep 2025 value amounting to $115.6 million.

  • Opko Health's Receivables fell 12.62% to $115.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $506.0 million, marking a year-over-year increase of 5.77%. This contributed to the annual value of $143.0 million for FY2024, which is 14.08% up from last year.
  • Opko Health's Receivables amounted to $115.6 million in Q3 2025, which was down 7.82% from $125.4 million recorded in Q2 2025.
  • In the past 5 years, Opko Health's Receivables registered a high of $322.9 million during Q1 2021, and its lowest value of $107.3 million during Q2 2024.
  • For the 3-year period, Opko Health's Receivables averaged around $130.9 million, with its median value being $123.6 million (2023).
  • In the last 5 years, Opko Health's Receivables surged by 140.60% in 2021 and then tumbled by 49.72% in 2022.
  • Quarterly analysis of 5 years shows Opko Health's Receivables stood at $261.5 million in 2021, then plummeted by 49.72% to $131.5 million in 2022, then declined by 4.64% to $125.4 million in 2023, then rose by 14.08% to $143.0 million in 2024, then dropped by 12.62% to $115.6 million in 2025.
  • Its last three reported values are $115.6 million in Q3 2025, $125.4 million for Q2 2025, and $121.9 million during Q1 2025.